Sorcero vs ElevenLabs
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI intelligence platform for life sciences. $42.5M Series B (Nov 2025). Google Cloud Partner Award. Agentic workflows for medical affairs. Founded in DC area.
About
Sorcero is an AI intelligence platform purpose-built for life sciences companies, serving the unique information needs of medical affairs, regulatory affairs, and clinical teams who must synthesize vast and rapidly evolving bodies of scientific literature, competitive intelligence, and clinical evidence. The company was founded on the recognition that the life sciences industry's information workflows are both extraordinarily high-stakes and chronically underserved by general-purpose AI tools that lack domain-specific training and compliance-aware design.\n\nThe platform provides agentic AI workflows that automate and augment the work of medical science liaisons, regulatory teams, and evidence synthesis specialists — tasks that traditionally require extensive manual effort to gather, assess, and communicate scientific evidence to internal and external stakeholders. Sorcero's technology is trained on life sciences-specific data and designed to meet the accuracy and traceability standards that regulated industries require, differentiating it from general AI document and knowledge management tools that cannot provide the provenance and citation depth that medical affairs functions demand.\n\nSorcero closed a $42.5 million Series B in November 2025 and has been recognized as a Google Cloud Partner Award winner, validating both its technical infrastructure and its standing within the enterprise AI ecosystem. The company operates in a market where AI adoption in medical affairs and regulatory functions is accelerating as pharma and biotech companies seek to compress the time between scientific evidence generation and stakeholder communication. Sorcero's specialized positioning in life sciences AI gives it a defensible niche in a sector where generic AI deployments frequently fail to meet the precision and compliance standards required.
$500M Series D at $11B valuation (Feb 2026) — largest voice AI funding round ever. $330M ARR; 1M+ developers using the API. Enterprise customers: Deutsche Telekom, Revolut, Meta, Salesforce. Voices in 32 languages; real-time cloning from 1 second of audio.
About
ElevenLabs was founded in 2022 by Piotr Dabkowski and Mati Staniszewski, two former Google and Palantir engineers who set out to break the language barrier using AI voice technology. The company specializes in AI-powered voice synthesis, cloning, and dubbing, enabling developers and enterprises to generate human-quality speech in over 30 languages. Its core technology combines deep learning models trained on massive speech datasets to produce natural-sounding voices indistinguishable from real humans.\n\nElevenLabs offers a suite of products including its flagship text-to-speech API, voice cloning tools, and an AI dubbing platform that localizes video content while preserving the speaker's original voice. Its products target a broad audience—from indie developers building audio apps to large enterprises deploying voice interfaces at scale. Key differentiators include ultra-low latency streaming synthesis, fine-grained voice customization, and a growing library of pre-built AI voices across accents and styles.\n\nElevenLabs has grown rapidly, surpassing $330M in annualized revenue and serving over 1 million developers. Enterprise clients include Deutsche Telekom, Spotify, and leading media companies. In February 2026, the company closed a $500M Series D at an $11B valuation, cementing its position as the market leader in AI voice. Its APIs power podcasts, audiobooks, video games, and customer service bots worldwide, making ElevenLabs the default infrastructure layer for AI-generated audio.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.